Magenlom (Omeprazole)

Omeprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells in the stomach. This blockade stops the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of both basal and stimulated acid output.

The appropriate dose of Magenlom is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and treatment duration. Dosage regimens are individualized and should follow the prescriber’s instructions and local clinical guidelines.

Safety data for omeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers should evaluate the risk‑benefit profile for each patient and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Magenlom. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Magenlom (omeprazole) belongs to the proton pump inhibitor (PPI) class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established efficacy and safety profile, making it a common first‑line option for acid‑related disorders.

Magenlom should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Magenlom is taken orally, usually as a tablet or capsule, with a glass of water. It can be taken with or without food, but for optimal absorption it is often recommended to swallow the dose at least 30 minutes before a meal. Follow the prescriber’s instructions regarding timing and frequency.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, low magnesium levels leading to muscle cramps or cardiac arrhythmias, increased risk of bone fractures with long‑term use, and rare skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Magenlom should be avoided in patients with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking medications that have major interactions (e.g., clopidogrel, atazanavir, methotrexate), and patients requiring long‑term acid suppression without clear indication.